Business Context and Reporting Period
This Form 8-K was filed by Griffin-American Healthcare REIT IV, Inc. on July 27, 2016, reporting events occurring on July 25, 2016. The registrant is a Maryland corporation focused on acquiring medical office buildings. The filing details the entry into a material definitive agreement to purchase a specific property.
Key Financial Metrics and Transaction Details
The filing does not provide consolidated revenue, profit, cash flow, or margin data for the company. The primary financial metric disclosed relates to a specific acquisition:
- Asset: Charlottesville MOB, a 74,000-square-foot medical office building in Charlottesville, Virginia.
- Purchase Price: $20,120,000 plus closing costs.
- Occupancy: Approximately 95% leased to three tenants (Martha Jefferson Hospital, University of Virginia Physicians Group, and the U.S. Department of Veterans Affairs).
- Deposit: $500,000 due within three business days of the effective date.
- Escrow Holdback: $300,000 to be held for 12 months post-closing.
- Financing Source: Funds raised through the company's initial public offering (IPO).
Material Changes and Transaction Terms
The material change is the execution of an Agreement of Sale with PJP Building Five, L.C. Key terms include:
- Due Diligence: A 30-day period with a right to terminate for any reason prior to expiration, resulting in a full deposit refund.
- Closing Timeline: Anticipated within 15 days following the expiration of the due diligence period (targeting the third quarter of 2016).
- Debt Assumption: The seller is obligated to defease the existing loan and satisfy a first lien deed of trust at their sole cost and expense.
- Default Remedies: If the seller defaults, the buyer may terminate and recover the deposit plus up to $75,000 in out-of-pocket costs, or seek specific performance.
Outlook, Risks, and Management Commentary
Management anticipates closing the acquisition in the third quarter of 2016 but explicitly states there is no assurance that the closing will occur within this timeframe or at all. The transaction is subject to substantial conditions to closing. Additionally, the company anticipates paying an acquisition fee to its advisor based on the purchase price, as described in the IPO prospectus.
Investor Verification Checklist
- Verify the successful completion of the due diligence period and the absence of termination notices.
- Confirm the seller's ability to defease the existing loan and satisfy the $250,000 or less in other monetary encumbrances by the closing date.
- Monitor the status of the company's initial public offering to ensure sufficient funds are available for the $20.12 million purchase price.
- Review the full Agreement of Sale (Exhibit 10.1) for specific representations and warranties not detailed in the summary.